Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?

被引：8
|
作者：
Dapra, Valentina [1 ,2 ]
Airoldi, Marco [1 ,2 ]
Bartolini, Michela [1 ,2 ]
Fazio, Roberta [1 ,2 ]
Mondello, Giuseppe [2 ]
Tronconi, Maria Chiara [2 ]
Prete, Maria Giuseppina [2 ]
D'Agostino, Giuseppe [3 ]
Foppa, Caterina [1 ,4 ]
Spinelli, Antonino [1 ,4 ]
Puccini, Alberto [2 ]
Santoro, Armando [1 ,2 ]
机构：
[1] Humanitas Univ, Dept Biomed Sci, I-20072 Pieve Emanuele, Italy
[2] IRCCS Humanitas Res Hosp, Humanitas Canc Ctr, Med Oncol & Hematol Unit, I-20089 Rozzano, Italy
[3] IRCCS Humanitas Res Hosp, Radiotherapy & Radiosurg Dept, I-20089 Rozzano, Italy
[4] IRCCS Humanitas Res Hosp, Div Colon & Rectal Surg, I-20089 Rozzano, Italy
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 15期
关键词：
locally advanced rectal cancer; total neoadjuvant therapy; rectal cancer; nonoperative management; ct-DNA; MMR-deficient tumor; TOTAL MESORECTAL EXCISION; SHORT-COURSE RADIOTHERAPY; METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL; PREOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; OPEN-LABEL; POSTOPERATIVE CHEMORADIOTHERAPY; FOLLOW-UP;
D O I：
10.3390/ijms241512159
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The therapeutic landscape in locally advanced rectal cancer (LARC) has undergone a significant paradigm shift in recent years with the rising adoption of total neoadjuvant treatment (TNT). This comprehensive approach entails administering chemotherapy and radiation therapy before surgery, followed by optional adjuvant chemotherapy. To establish and deliver the optimal tailored treatment regimen to the patient, it is crucial to foster collaboration among a multidisciplinary team comprising healthcare professionals from various specialties, including medical oncology, radiation oncology, surgical oncology, radiology, and pathology. This review aims to provide insights into the current state of TNT for LARC and new emerging strategies to identify potential directions for future research and clinical practice, such as circulating tumor-DNA, immunotherapy in mismatch-repair-deficient tumors, and nonoperative management.
引用
收藏
页数：16
相关论文
共 50 条
  • [31] Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial
    Bahadoer, Renu R.
    Hospers, Geke A. P.
    Marijnen, Corrie A. M.
    Peeters, Koen C. M. J.
    Putter, Hein
    Dijkstra, Esmee A.
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    van Etten, Boudewijn
    Nilsson, Per J.
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    EUROPEAN JOURNAL OF CANCER, 2023, 185 : 139 - 149
  • [32] Outcomes of Locally Advanced Rectal Cancer Patients Treated with Total Neoadjuvant Treatment: A Meta-Anaysis of Randomized Controlled Trials
    Gabbani, Milena
    Giorgi, Carlotta
    Napoli, Giuseppe
    Tebano, Umberto
    Perrone, Maria Sole
    Missiroli, Sonia
    Berretta, Massimiliano
    Mandara, Marta
    Zaninelli, Marta
    Luca, Nicoletta
    Grigolato, Daniela
    Muraro, Marco
    Rinaldi, Giulia
    Pinton, Paolo
    Fiorica, Francesco
    CLINICAL COLORECTAL CANCER, 2022, 21 (04) : 297 - 308
  • [33] Current Trends in the Treatment of Locally Advanced Rectal Cancer: Where We Are and How We Got Here
    Shulman, Rebecca M.
    Meyer, Joshua E.
    CURRENT COLORECTAL CANCER REPORTS, 2021, 17 (06) : 88 - 102
  • [34] Total neoadjuvant treatment in locally advanced rectal cancer
    De Felice, Francesca
    Tombolini, Vincenzo
    Cortesi, Enrico
    TRANSLATIONAL ONCOLOGY, 2021, 14 (05):
  • [35] Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview
    Guida, Andrea M.
    Sensi, Bruno
    Formica, Vincenzo
    D'Angelillo, Rolando M.
    Roselli, Mario
    Blanco, Giovanna Del Vecchio
    Rossi, Piero
    Capolupo, Gabriella T.
    Caricato, Marco
    Sica, Giuseppe S.
    BIOLOGY DIRECT, 2022, 17 (01)
  • [36] Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer
    Zaborowski, A.
    Stakelum, A.
    Winter, D. C.
    BRITISH JOURNAL OF SURGERY, 2019, 106 (08) : 979 - 987
  • [37] Is total neoadjuvant treatment beneficial for locally advanced rectal cancer? a meta-analysis of randomized controlled trials
    Wu, Hai-Qiong
    Li, Jun
    Miao, Ji-Dong
    Li, Jia-Wei
    ONCOLOGY, 2024, 102 (05) : 399 - 413
  • [38] Future direction of total neoadjuvant therapy for locally advanced rectal cancer
    Kagawa, Yoshinori
    Smith, J. Joshua
    Fokas, Emmanouil
    Watanabe, Jun
    Cercek, Andrea
    Greten, Florian R.
    Bando, Hideaki
    Shi, Qian
    Garcia-Aguilar, Julio
    Romesser, Paul B.
    Horvat, Natally
    Sanoff, Hanna
    Hall, William
    Kato, Takeshi
    Roedel, Claus
    Dasari, Arvind
    Yoshino, Takayuki
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (6) : 444 - 455
  • [39] Total neoadjuvant therapy for locally advanced rectal cancer A meaningful treatment option?
    Lauscher, Johannes
    Stintzing, Sebastian
    Boehmer, Dirk
    COLOPROCTOLOGY, 2022, 44 (04) : 221 - 228
  • [40] Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!
    Ozer, Leyla
    Yildiz, Ibrahim
    Bayoglu, Vedat
    Bozkurt, Mustafa
    Esen, Eren
    Remzi, Feza H.
    Gogenur, Ismail
    Aytac, Erman
    COLORECTAL DISEASE, 2021, 23 (07) : 1662 - 1669
12345